Post by JAMA Psychiatry on X. Psilocybin. Bipolar

pk879tod_normal.png spacer.png
JAMA Psychiatry
⁦‪@JAMAPsych‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Findings suggest efficacy and safety of psilocybin in bipolar II depression and support further study of psychedelics in this population. ja.ma/3KxuCFG
6/9/24, 9:00 AM

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment